Quick Facts

• Addresses: Symptoms related to excess stomach acid production.
• Primary Uses: Management of certain gastric and duodenal ulcers.
• Other Uses: Temporary relief of heartburn and acid indigestion.

---

Acimax is a pharmaceutical agent indicated for the treatment of specific conditions related to excessive stomach acid. The medication is used to manage symptoms associated with gastroesophageal reflux disease (GERD), a chronic condition where stomach contents move back into the esophagus.

Acimax is commonly prescribed as a therapeutic option for both gastric ulcers and duodenal ulcers, and may assist in the healing process of the lining of the stomach and duodenum. Additionally, the compound provides relief from occasional symptoms of heartburn and acid indigestion.

Regulatory References

1. NIH MedlinePlus guidance

Official Eligibility for Acimax

Acimax, a fixed-dose combination of an NSAID (Aceclofenac) and a PPI (Omeprazole), is officially intended for use only in adults. Safety and efficacy for the combination are not established in pediatric patients, and the medicine is generally not recommended for use in children or adolescents.

---

Absolute Contraindications (Must Not Use)

Official regulatory documents state that Acimax is contraindicated for several populations, primarily due to the risks associated with the NSAID component. It must not be used in patients with a known hypersensitivity to Aceclofenac, Omeprazole, or other NSAIDs/aspirin. Use is also prohibited in individuals with severe, established cardiovascular conditions (e.g., NYHA II–IV heart failure), active or a history of recurrent peptic ulcers, or severe hepatic and renal failure.

Age and Condition-Based Restrictions

Eligibility is restricted for certain age groups and physiological states. The medicine is contraindicated in the third trimester of pregnancy due to risks to the fetus. Use during the first and second trimesters and while lactating is generally not recommended. For older adults and those with mild-to-moderate renal or hepatic impairment, use requires caution and close monitoring, often requiring the lowest effective dose.

Interactions with other medicines and products

Interaction Scope

The interaction profile of Acimax combines the documented effects of its two components: the NSAID Aceclofenac and the PPI Omeprazole. These interactions are classified by regulatory authorities based on metabolic changes, altered absorption, and combined pharmacodynamic risk.

Interaction Classification	Examples of Interacting Substances
Formally Contraindicated	Nelfinavir, Rilpivirine (Omeprazole component)
Metabolic/Exposure-Altering	Warfarin, Phenytoin, Diazepam, Voriconazole
pH-Dependent Absorption	Atazanavir, Ketoconazole, Itraconazole
Pharmacodynamic Risk	Other NSAIDs, Anticoagulants, Diuretics, SSRIs

Official Regulatory Information

Omeprazole is a known inhibitor of the CYP2C19 enzyme, which can increase the systemic exposure of co-administered medicines that are CYP2C19 substrates, such as Phenytoin and Diazepam. Concomitant use with CYP2C19 inhibitors like Voriconazole may in turn raise Omeprazole plasma levels. The co-administration of Omeprazole with pH-dependent drugs, including the antivirals Nelfinavir and Atazanavir, is officially restricted due to the reduction in plasma concentration of the latter substances, which risks loss of therapeutic effect.

Aceclofenac's NSAID profile enhances the risk of gastrointestinal adverse effects when combined with other NSAIDs, corticosteroids, or SSRIs. It may also reduce the effect of antihypertensives like ACE-inhibitors and diuretics. Combining Aceclofenac with diuretics increases the risk of nephrotoxicity, a concern explicitly noted for the elderly and those with impaired renal function.

Mechanism of Action: How Acimax Works

Acimax functions across three distinct mechanistic domains, beginning with its action as an antagonist at specific cell-surface receptors central to inflammatory signaling. This interaction physically blocks the binding of pro-inflammatory chemical messengers (cytokines), thereby limiting the magnitude of early signal transduction within the affected cells.

The downstream cascade involves the modulation of immune cell activity, specifically restricting the activation and migration of key cell types, such as T-cells. This functional restriction results in sustained modulation of local immune cell output and restricts the subsequent release of secondary inflammatory mediators into the tissue environment.

A complementary mechanism involves the inhibition of matrix-degrading enzymes, primarily Matrix Metalloproteinases (MMPs), which are present at heightened concentrations during dysregulated tissue states. This enzymatic inhibition alters the signaling cascade associated with structural turnover and restricts the degradation of extracellular matrix components, including collagen. This integrated multi-domain action results in the overall physiological adjustment of local immune and tissue responses.

Official Administration Guidelines for Acimax

This section outlines the standardized protocol for the use of the fixed-dose combination product containing Aceclofenac 100 mg and Omeprazole 20 mg, as specified for this formulation.

Use Parameter	Official Instruction
Route of Administration	Oral
Standard Adult Dose	One tablet (Aceclofenac 100 mg / Omeprazole 20 mg)
Dosing Frequency	Once daily
Duration of Use	Continues for the required period of long-term anti-inflammatory therapy

The fixed-dose combination is an enteric-coated tablet supplied strictly for oral administration. To maintain the delayed-release properties and ensure the integrity of the Omeprazole component, the tablet must be swallowed whole with liquid and must not be crushed, chewed, or split. While the tablet can be taken with or without food, the once-daily administration is typically scheduled for the morning.

The standard adult dose is fixed at one tablet, aligning the Omeprazole content with the 20 mg regimen recommended for the prevention of NSAID-associated gastric and duodenal ulcers in patients deemed at risk. The duration of this treatment is generally commensurate with the patient's need for continued long-term anti-inflammatory therapy.

Specific instructions apply to certain populations. Dosing adjustments are not necessary for the elderly or those with mild renal impairment. For patients with hepatic impairment, an initial dose corresponding to 100 mg Aceclofenac per day is suggested. The product is not recommended for use in children under 18 years of age. If a scheduled daily dose is missed, patients should resume the regular schedule with the next tablet and must not take a double dose to compensate.

This procedural structure is designed to guide the consistent, uniform use of the medication as defined for the product.

Research Evidence / Overview of Studies

Research on Acimax in Neuropathic Pain

Research has explored whether Acimax may be used in the management of chronic neuropathic pain. Studies evaluated the effect of the compound on pain symptoms. Studies tracked participant changes over specified timeframes.

---

Study Protocols

Research focused on the compound combination being studied. Studies examined the course and duration of recorded changes.

The research was conducted using pre-defined protocols for initial treatment and subsequent adjustment. Studies included extended follow-up periods.

---

Scope of Research

Study protocols specified certain pre-existing conditions as exclusion criteria. Other exclusion criteria included specific health statuses and co-administered medications. The studies were conducted as randomized, controlled trials (RCTs).

Key Studies & References

1. Neuropathic pain in adults: pharmacological management in non-specialist settings (Clinical guideline CG173)

Common questions about Acimax (FAQ)

---

Q: Can I take Acimax every day for my chronic pain?

The decision to use Acimax daily for chronic conditions, such as arthritis, should be made in consultation with a healthcare professional. Product labeling generally advises using the lowest effective dose for the shortest duration necessary. Long-term or high-dose use is associated with an increased risk of potential adverse effects, including kidney problems and gastrointestinal irritation (e.g., stomach bleeding).

Patients on long-term therapy may be advised by their healthcare provider to monitor blood pressure and discuss the need for protective measures for the stomach.

---

Q: How long does it take for Acimax to start working?

Acimax's onset of action is generally observed between 30 and 60 minutes after administration, though individual response times may vary. The drug's peak effect is typically seen within 1 to 2 hours.

While taking this medication on an empty stomach may lead to faster absorption, taking it with food or milk is sometimes recommended to minimize stomach upset. This choice should be discussed with a healthcare professional.

---

Q: Is Acimax safer than other pain relievers?

Acimax is associated with a lower risk of certain types of liver toxicity compared to acetaminophen (paracetamol) when used within recommended guidelines, but it carries other distinct risks. The primary concerns associated with Acimax include a higher potential for stomach bleeding and kidney issues, especially with prolonged use or in certain populations like older adults.

Concerns about specific side effects and determining the most appropriate pain reliever should be discussed with a healthcare provider, who can recommend the best option based on an individual's complete health profile and existing conditions.

How to Store and Dispose of Acimax?

Acimax tablets must be stored at Controlled Room Temperature, specifically between 20 C and 25 C (68 F and 77 F). The medication must be kept in its original container and the container must remain tightly closed to ensure protection from moisture and excessive heat, as these factors can compromise the integrity of the tablets. To maintain safety, Acimax must be stored out of the reach of children.

---

Disposal Requirements

Expired or unused Acimax should not be flushed down the toilet or poured into any drain. Disposal must follow local regulations or utilize a recognized drug take-back program to ensure the medicine is discarded safely and environmentally soundly.